Navigation Links
Study Probes Difference Between Embryonic, Adult Stem Cells
Date:10/10/2007

Each develops in unique ways, researchers say

WEDNESDAY, Oct. 10 (HealthDay News) -- Adult stem cells lack a protein called Oct4, which helps maintain embryonic stem cells in an undifferentiated state, U.S. researchers report.

The findings suggest that the ability of stem cells to change into any kind of cell is regulated differently in adult and embryonic stem cells, the researchers said. The study also challenges findings from more than 50 studies that concluded that Oct4 was present in adult stem cells.

Using three independent detection methods to analyze six types of tissue in which Oct4-positive adult stem cells have been reported, the authors of the new study concluded that Oct4 was not present, or was present at only statistically insignificant levels, in these tissues.

The researchers at the Whitehead Institute for Biomedical Research in Cambridge, Mass., also found that Oct4 is not required to maintain mouse adult stem cells in their undifferentiated state and that adult tissues functioned normally when the Oct4 gene was deleted.

The study was published online Oct. 10 in the journal Cell Stem Cells.

Earlier studies may have misapplied analytical techniques or worked with cell cultures that had spent too much time in an incubator, said author Christopher Lengner, a postdoctoral fellow at the Whitehead Institute.

He and his team are now studying the mechanisms used by adult stem cells to change into any kind of cell.

"Is there a common pathway that governs stemness in adult stem cells, or does each stem cell have its own pathway? We don't know yet," Lengner said in a prepared statement.

More information

The U.S. National Institutes of Health has more about stem cells.



-- Robert Preidt



'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 2Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 3Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 4Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 2Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 3Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 4Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 5Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 6